Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PHAR 358 > Multiple Sclerosis > Flashcards

Multiple Sclerosis Flashcards

1
Q

Decribe the pathophysiology of MS

A

There is inflammation of the myelin sheath which leads to demyleination, which exposes the axon and leads to axonal degeneration in the CNS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Although the cause of MS is unknown, what are some potential causes (etiology)? (4)

A
  1. Immunological
  2. Genetic
  3. Environmental
  4. Infectious
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are some symptoms of MS? (4)

A
  1. Numbness, tingling
  2. Vision problems
  3. Walking difficulty
  4. Brain fog
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are 3 unique symptoms of MS?

A
  1. Lhermitte’s sign
  2. Uhtohoff’s phenomena (heat intolerance)
  3. MS hug - feels a tightness around the midsection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the 4 types of MS?

A
  1. Relapsing-remitting
  2. Primary progressive
  3. Secondary progressive
  4. Clinically isolated syndrome (CIS)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the 2 most common types of MS?

A
  1. Relapsing-remitting
  2. Secondary progressive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe relapsing-remitting MS

A

Cycles of remitting where there are no symptoms then relapse where the symptoms flare up. Cannot predict when relapses occur, it can be years in between or multiple per year.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe secondary progressive MS

A

Eventually, after relapsing and remitting for a long period of time, the person goes on to develop this type of MS where the person does not return back to their baseline after a relapse. Axon damage can only be repaired so many times - the majority of RR MS will turn into this.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe primary progressive MS

A

Individuals who have progressive disease right from the start. Never cycles, just has symptoms all the time. Mostly men who are diagnosed with this

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe clinically isolated syndrome (CIS)

A

Someone has an episode of clinical symptoms, it resolves, then they never go on for a 2nd attack

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Men vs. Women: Who is more affected by MS?

A

Women ~3:1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Remember the “Natural History of MS” chart. What is happening with brain volume, axonal loss, disability, and inflammation over time?

A
  1. Brain volume - shrinks over time at a higher rate with MS compared to normal
  2. Axonal loss - linear line over time
  3. Disability - RR cycles see disability go up and down until it progresses to secondary progressive, where the line only goes up
  4. Inflammation - with active relapses, inflammation is high. Eventually the inflammation goes down with time because the axons are already damaged, at that point the patient is going to be in secondary progressive MS.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The Expanded Disability Status Scale (EDSS) is a way of trying to classify the level of disability from MS. What number is the magic threshold? Why?

A

6
At this point, no longer able to walk 100m without some kind of assistance. A lot of studies focus on EDSS <6 so there is not much evidence at 6+. Also, formularies only approve drugs for people <6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are 3 non-pharmacological ways to manage MS?

A
  1. Exercise
  2. Diet (just eating healthy, no specific diet)
  3. Complementary/alternative medicine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are 3 pharmacological ways to manage MS?

A
  1. Treat acute relapses
  2. Treat/manage symptoms
  3. Prevent disease activity and progression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Define an MS relapse

A

New or worsening symptoms, last greater than or equal to 24 hrs, absence of fever (infection) or other causes, and be separated from previous relapse by greater than or equal to 30 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How are MS relapses managed? (3)

A
  1. High-dose corticosteroids
    - Methylprednisone IV (500mg-1000mg x3-5 days) - may or may not have oral taper
    - Oral option = 1250mg prednisone = 1000mg IVMP
  2. Non-responders may consider plasma exchange
  3. Not all relapses are treated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

The #1 reason why people leave the workforce due to MS is because of what symptom?

A

Fatigue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Primary fatigue is caused by MS. Why?

A

More energy needed b/c of damaged CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Secondary fatigue is caused b/c of living with MS. Why? (4)

A
  1. Depression
  2. Pain
  3. Spasms
  4. Sleep disturbances
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are 4 non-pharmacological ways to manage MS fatigue?

A
  1. OT/PT
  2. Sleep hygiene
  3. Avoid excessive heat
  4. Exercise and diet
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are 3 pharmacological ways to manage MS fatigue?

A
  1. Amantadine
  2. Modafinil
  3. Methylphenidate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the drawbacks of amantadine, modafinil, and methylphenidate in MS use?

A
  1. Amantadine - insomnia/sleep disturbances
  2. Modafinil - headache, insomnia, SJS - also fetal abnormalities
  3. MPH - insomnia, anxiety, dizziness
    Also, in general none of these work particularly well, can try, but success varies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are 3 non-pharmacological ways to manage poor gait in MS?

A
  1. OT/PT
  2. Bracing/walking aids
  3. Exercise
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the drug used to treat poor gait in MS? How do we feel about it?

A

Fampridine - we don’t really like it. Increases walking speed is all, doesn’t help walk better.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are the side effects of fampridine? (5)

A
  1. UTI
  2. Insomnia
  3. Headache
  4. Dizziness
  5. Seizure risk (dose-dependent)
    (Pregnancy and breastfeeding risk unknown)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What are the 2 non-pharm management methods for MS spasticity?

A
  1. Exercise
  2. Stretching
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are 3 drugs used to treat MS spasticity?

A
  1. Baclofen - GI issues, drowsiness
  2. Gabapentin - drowsiness, nausea, blurred vision
  3. Botulinum toxins - pain, bruising
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What cannabis med is indicated in MS?

A

Sativex

30
Q

When is Sativex indicated in MS?

A

Indicated as add-on treatment of spasticity and pain in MS

31
Q

What are the potential ADRs of Sativex? (6)

A

1. Long-term cognition effects
2. Fatigue
3. Dizziness
4. Blurred vision
5. Tachycardia
6. Falls

32
Q

What are the problems with using cannabis in MS treatment?

A
  1. Lack of evidence for use in any other MS symptoms
    - Poor quality studies (or none)
  2. Challenges:
    - Dosage/ratio unknown
    - Type of cannabinoid(s) to use
    - Varying quantity/quality if street cannabis
    - Finding cannabis “naive” study participants
33
Q

What are the goals of MS disease-modifying therapies (DMTs)? (4)

A
  1. Attempt to slow the inflammatory process
  2. Decrease frequency and severity of relapses
  3. Decrease lesions on MRI
  4. Reduce accumulation of neurological impairment and disability over time (?)
34
Q

With DMTs, _______ is better

A

earlier

35
Q

What are the 5 injectable DMT MS medications?

A
  1. Interferon beta-1b
  2. Glatiramer acetate
  3. Interferon beta-1a
  4. Peginterferon beta-1a
  5. Ofatumumab
36
Q

What are the 7 oral DMT MS medications?

A
  1. Fingolimod
  2. Dimethyl fumarate
  3. Teriflunomide
  4. Cladribine
  5. Siponimod
  6. Ozanimod
  7. Ponesimod
37
Q

What are the 4 infused DMT MS medications?

A
  1. Natalizumab
  2. Alemtuzumab
  3. Ocrelizumab
  4. Rituximab
38
Q

Every DMT MS med is an immunosuppressant except which 2?

A
  1. Interferon-beta - immunomodulating agent
  2. Glatiramer acetate - immunostimulator
39
Q

What is the MOA of dimethyl fumarate?

A

Complex mechanism involving decreased CD40 B-cell and T-cell activation

40
Q

What is the MOA of teriflunomide?

A

Inhibits expansion of lymphocytes in response to a stimulus

41
Q

What is the MOA of fingolimod, siponimod, ozanimod, and ponesimod?

A

Continuous supression of peripheral lymphocytes

42
Q

What is the MOA of natalizumab?

A

Compartmentalized immunosuppressant in the CNS only

43
Q

What is the MOA of ocrelizumab and ofatumumab?

A

Inhibition of CD20 lymphocytes

44
Q

What is the MOA of alemtuzumab and cladribine?

A

Actions consistent with a mechanism involving immune reconstitution

45
Q

What is progressive multifocal leukoencephalopathy (PML)? (3)

A
  1. Opportunistic infection by JC virus (40-90% of population is JCV+)
  2. Destroys the cells that produce myelin (clumsiness, weakness, changes to vision and speech)
  3. No cure - “fix” reason for immunosupression (stop meds, plasma exchange if needed)
46
Q

What DMT MS meds is PML mostly seen with? (4)

A

1. Natalizumab
2. Dimethyl fumarate
3. Fingolimod
4. Ocrelizumab

47
Q

How often is interferon-beta-1b dosed?
How about interferon-beta-1a (2 for this one)?

A

1b = Every other day (SC)
1a = Weekly (IM) or 3/week (SC)

48
Q

How often is peginterferon beta-1a dosed?

A

Every 2 weeks (SC)

49
Q

How often is glatiramer acetate dosed? (2 different ones depending on brand)

A
  1. SC once daily
  2. SC 3/week
50
Q

What is the unique side effect of glatiramer acetate?

A

Lipoatrophy - breakdown of fat tissue under the skin, resulting in divots. Caused after a lot of SC injecting of the drug.

51
Q

How is ofatumumab dosed? (different on week 1-3 than week 5)

A

Week 1-3 = SC weekly
Week 5 = SC every 4 weeks

52
Q

How often is teriflunomide dosed?

A

Once daily

53
Q

What is the unique side effect of teriflunomide to be aware of?

A

Potetnial teratogen for MALES AND FEMALES

54
Q

How often is dimethyl fumarate dosed?

A

BID (titrate BID for 1 week)

55
Q

What is the unique side effect of dimethyl fumarate?

A

Lymphopenia

56
Q

How often is fingolimod, siponimod, ponesimod, and ozanimod dosed?

A

OD

57
Q

What is an important ADR to be aware of for fingolimod, siponimod, ponesimod and ozanimod?

A

Potential teratogen - need a washout period (2-3 months for fing, pones and ozan, 10 days for sip)

58
Q

Siponimod is indicated for which MS types specifically?

A

SPMS
RRMS

59
Q

What needs to be monitored when starting fingolimod?

A

First dose cardiac observation for 6 hours

60
Q

How is cladribine dosed?

A

Once daily for 4 or 5 consecutive days beginning of each of the first 2 months of Years 1 and 2 of treatment

61
Q

What is the unique ADR of cladribine to be aware of?

A

Potential teratogen for MALES AND FEMALES

62
Q

How often is natalizumab dosed?

A

Every 4 weeks

63
Q

What is the unique ADR of natalizumab to be aware of?

A

PML (especially if used > 2 years)

64
Q

How often is ocrelizumab dosed?

A

Infused at week 0 and week 2, then every 24 weeks

65
Q

What are 3 unique ADRs of ocrelizumab to be aware of?

A
  1. Infusion reactions - pre-medicate with IVMP and antihistamine 30-60 mins prior to infusion
  2. PML potential
  3. Potential teratogen
66
Q

What should be screened for before using ocrelizumab?

A

Hep B (avoid ocre if +)

67
Q

Ocrelizumab is indicated for which MS types?

A

PPMS
RRMS

68
Q

How often is alemtuzumab dosed? (two courses)

A

First course - 12mg IV OD for 5 consecutive days
Second course - 12mg IV OD for 3 consecutive days at month 12 from additional course

69
Q

What are 2 common ADRs of alemtuzumab to be aware of?

A
  1. Infusion reactions (up to 2 hours after infusion finished)
  2. Monitoring of ADR (especially autoimmune ones for 4 years after last dose)
70
Q

What are some patient-specific factors to consider when choosing a DMT med? (4)

A
  1. Age
  2. Sex
  3. Lifestyle factors
  4. Pregnancy/breastfeeding
71
Q

What are disease-specific factors to consider when choosing a DMT med? (3)

A
  1. Disease course
  2. Prognosis
  3. Disease activity
72
Q

Vaccines in MS patients. Yay or nay?

A

Depends:
1. Inactivated vaccines - generally safe
2. Live and live-attenuated - generally not recommended (esp if taking DMT)
3. Wait until 4-6 weeks after relapse onset

PHAR 358 (16 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions